Abstract
Objective To explore the mechanism of vasoactive intestinal peptide (VIP) inducing angiogenesis by detecting the vascular endothelial growth factor (VEGF) mRNA content and microvessel density (MVD) in experimental prostate cancer in vivo.Methods Nude mice were subcutaneously injected with LNCaP prostate cancer cells.Cells were incubated for 1 h in the presence (experimental group) or absence (control group) of 100 nmol/L VIP for 1 h before xenograf.By measuring the transplanted tumor volume,real-time quantitative polymerase chain reaction (Real-time PCR) was used to detect VEGF mRNA,and CD34 was applied to calculate the MVD in the transplanted tumor tissue at 8th day and 15th day.Results The tumor volume,VEGF mRNA content and MVD in the experimental group [(55.38 ± 10.82),(89.41 ±15.66) mm3; 1.38±0.41,1.76 ±0.67; 43.7±11.4,59.1 ± 13.8] were significantly increased as compared with those in the control group [(28.56 ±7.39),(48.73 ± 12.48) mm3 ;0.42±0.13,0.59±0.24; 26.3 ±9.2,30.6±10.5; P＜0.05].Conclusion This study indicatesVIP promotes the growth of LNCaP cells probably by inducing angiogenesis in vivo. Key words: Prostate carcinoma; Vasoactive intestinal peptide; Vascular endothelial growth factor; Microvessel density
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
